Show simple item record

dc.contributor.authorPavlidis, Nicholasen
dc.contributor.authorPentheroudakis, Georgeen
dc.creatorPavlidis, Nicholasen
dc.creatorPentheroudakis, Georgeen
dc.date.accessioned2018-06-22T09:54:15Z
dc.date.available2018-06-22T09:54:15Z
dc.date.issued2010
dc.identifier.urihttps://gnosis.library.ucy.ac.cy/handle/7/42263
dc.description.abstractCancer of unknown primary (CUP) is a common, well-recognized and heterogeneous clinical syndrome. Patients with CUP present with metastatic disease in the absence of an identifiable primary tumour despite a diagnostic work-up. Aetiologically, CUP might either harbor primaries that cannot be detected by the standardized diagnostic investigations or carry distinct genetic and epigenetic aberrations. In this article we try to clarify the clinical and pathological enigma of CUP by answering 20 important questions related to this entity. © The Author 2010. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved.en
dc.language.isoengen
dc.sourceAnnals of Oncologyen
dc.subjectQuestionnairesen
dc.subjectEtoposideen
dc.subjectHumanen
dc.subjectNeoplasmsen
dc.subjectTamoxifenen
dc.subjectHumansen
dc.subjectBreast canceren
dc.subjectCancer growthen
dc.subjectCancer survivalen
dc.subjectCarboplatinen
dc.subjectComputer assisted tomographyen
dc.subjectPaclitaxelen
dc.subjectPlatinum derivativeen
dc.subjectPriority journalen
dc.subjectPrognosisen
dc.subjectTaxane derivativeen
dc.subjectPlatinumen
dc.subjectCancer stagingen
dc.subjectCytoreductive surgeryen
dc.subjectErlotiniben
dc.subjectCancer diagnosisen
dc.subjectCancer mortalityen
dc.subjectBone metastasisen
dc.subjectDisease courseen
dc.subjectConference paperen
dc.subjectImmunohistochemistryen
dc.subjectTumor differentiationen
dc.subjectAxillary lymph nodeen
dc.subjectHistopathologyen
dc.subjectLymph node dissectionen
dc.subjectMastectomyen
dc.subjectLymph node metastasisen
dc.subjectRisk factoren
dc.subjectCancer incidenceen
dc.subjectCarcinogenesisen
dc.subjectProstate canceren
dc.subjectLiver metastasisen
dc.subjectNuclear magnetic resonance imagingen
dc.subjectThorax radiographyen
dc.subjectIncidenceen
dc.subjectBevacizumaben
dc.subjectOctreotideen
dc.subjectAdenocarcinomaen
dc.subjectSquamous cell carcinomaen
dc.subjectDiagnostic valueen
dc.subjectBiologicalen
dc.subjectTumor markersen
dc.subjectCancer of unknown primary siteen
dc.subjectUnknown primaryen
dc.subjectTumor markeren
dc.subjectAromatase inhibitoren
dc.subjectEndoscopyen
dc.subjectCancer classificationen
dc.subjectNeuroendocrine tumoren
dc.subjectCervical lymph nodeen
dc.subjectPeritoneum canceren
dc.subjectGene expression profilingen
dc.subjectAntiandrogenen
dc.subjectGonadorelin agonisten
dc.subjectDeveloped countryen
dc.subjectDiagnostic imagingen
dc.subjectBone canceren
dc.subjectEpigeneticsen
dc.subjectKarnofsky performance statusen
dc.subjectMedical history takingen
dc.subjectRadiofrequency ablationen
dc.titleCancer of unknown primary site: 20 questions to be answereden
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1093/annonc/mdq278
dc.description.volume21
dc.description.issueSUPPL. 7en
dc.description.startingpagevii303
dc.description.endingpagevii307
dc.author.facultyΙατρική Σχολή / Medical School
dc.author.departmentΙατρική Σχολή / Medical School
dc.type.uhtypeArticleen
dc.contributor.orcidPavlidis, Nicholas [0000-0002-2195-9961]
dc.contributor.orcidPentheroudakis, George [0000-0002-6632-2462]
dc.gnosis.orcid0000-0002-2195-9961
dc.gnosis.orcid0000-0002-6632-2462


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record